Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
2022 · Nature Medicine · 226 citations
https://doi.org/10.1038/s41591-022-01962-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
859
Citations
12
h-index
17
i10-index
Ciaran McNamee is an academic researcher from University College Dublin. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers. The author has an h-index of 12, co-authored 35 publications.
https://doi.org/10.1038/s41591-022-01962-5
https://doi.org/10.1016/j.xjtc.2020.11.016
https://doi.org/10.1186/1752-1947-2-152
Click to start Chat